Published in Clin Infect Dis on February 01, 2007
Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev (2010) 3.58
The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective. Can J Infect Dis Med Microbiol (2015) 0.88
The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis (2007) 2.34
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep (2002) 6.51
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet (2006) 5.56
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med (2002) 4.88
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis (2011) 3.46
An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med (2003) 3.32
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis (2003) 2.29
Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med (2009) 2.25
Superspreading SARS events, Beijing, 2003. Emerg Infect Dis (2004) 2.03
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 2.03
Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis (2005) 2.03
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet (2009) 1.95
Perinatal infections due to group B streptococci. Obstet Gynecol (2004) 1.69
Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis (2005) 1.68
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67
Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 1.59
Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis (2003) 1.58
Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis (2004) 1.57
Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis (2002) 1.53
Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis (2002) 1.53
A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis (2007) 1.51
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J (2008) 1.50
Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis (2003) 1.49
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis (2004) 1.48
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47
Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep (2014) 1.44
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis (2004) 1.43
Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics (2006) 1.41
Severe acute respiratory syndrome, Beijing, 2003. Emerg Infect Dis (2004) 1.37
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health (2010) 1.33
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics (2010) 1.26
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet (2005) 1.23
Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol (2003) 1.19
The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet (2007) 1.17
Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol (2007) 1.17
Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique. Trop Med Int Health (2006) 1.15
Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia. Vaccine (2008) 1.15
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol (2003) 1.14
Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J Trop Pediatr (2009) 1.13
Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis (2003) 1.13
Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J (2004) 1.11
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. MMWR Surveill Summ (2011) 1.10
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. Vaccine (2002) 1.09
Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003. Vaccine (2008) 1.03
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. J Infect Dis (2003) 1.00
Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol (2007) 0.92
Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis (2002) 0.89
Sentinel surveillance: a reliable way to track antibiotic resistance in communities? Emerg Infect Dis (2002) 0.88
Streptococcus pneumoniae and Haemophilus influenzae type B Carriage, Central Asia. Emerg Infect Dis (2005) 0.88
Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatr Infect Dis J (2003) 0.87
Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service. Am J Epidemiol (2011) 0.87
Public health issues related to infection in pregnancy and cerebral palsy. Ment Retard Dev Disabil Res Rev (2002) 0.87
Invasive group-A streptococcal infection in an allograft recipient. A case report. J Bone Joint Surg Am (2007) 0.86
Infections in international pregnancy study: performance of the optical immunoassay test for detection of group B streptococcus. J Clin Microbiol (2003) 0.85
Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin Infect Dis (2004) 0.85
Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections. Emerg Infect Dis (2015) 0.83
Adults with invasive pneumococcal disease: missed opportunities for vaccination. Am J Prev Med (2006) 0.80
Implementing an Ebola Vaccine Study - Sierra Leone. MMWR Suppl (2016) 0.79
Delivering pneumococcal vaccine to a high risk population: the Navajo experience. Hum Vaccin (2005) 0.78
Barriers to implementing the group B streptococcal prevention guidelines. Birth (2002) 0.77
Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally. J Pediatr (2013) 0.77
Prevention of neonatal sepsis. Clin Perinatol (2005) 0.77
Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002. J Womens Health (Larchmt) (2003) 0.76
1918 and 2009: a tale of two pandemics. Public Health Rep (2010) 0.76
Perinatal group B streptococcal disease prevention, Minnesota. Emerg Infect Dis (2005) 0.75
A human papillomavirus type 16 vaccine. N Engl J Med (2003) 0.75
Protecting adults from influenza: tis the season to learn from the pandemic. J Infect Dis (2012) 0.75
Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes. Infect Dis Obstet Gynecol (2005) 0.75
Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era. Microbiol Spectr (2016) 0.75
Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung. Int J Tuberc Lung Dis (2010) 0.75
Global health and the US Centers for Disease Control and Prevention. Lancet (2014) 0.75